Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.

Tigecycline is an antibiotic agent with a broad spectrum, which has an antibacterial effect against many multidrug-resistant organisms. However, its clinical efficacy in the treatment of hospital-acquired pneumonia (HAP) is disputed.